The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
批准号:
10668549
负责人:
Sixto Manuel Leal
金额:
$66.83万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-05 至 2023-07-31
关键词:
2019-nCoVACE2AirAllergic Bronchopulmonary AspergillosisAnabolismAntifungal AgentsAspergillusAspergillus fumigatusAutopsyBiologicalBiological AssayBiologyBronchiolesBronchoalveolar LavageBronchoalveolar Lavage FluidCell Culture TechniquesCell DeathCell LineChemicalsChemotactic FactorsClustered Regularly Interspaced Short Palindromic RepeatsDataDevelopmentEnabling FactorsEpithelial CellsEvaluationExhibitsFormalinFunctional disorderGene ExpressionGerminationGrowthHemeHost DefenseHumanHyphaeImmuneImmune responseImmune systemImmunityImmunocompetentImmunohistochemistryIn SituIndividualInfectionInfection preventionIntensive Care UnitsInterferonsInterventionIronIron ChelationKnock-outLaboratoriesLightLiquid substanceLungMediatingModelingMoldsMusMycosesNeutrophil InfiltrationNutrientOxyhemoglobinParaffin EmbeddingPathway interactionsPatientsPharmacologyPredispositionProductionProteinsRIPK1 geneRIPK3 geneRegimenReproduction sporesRespiratory SystemRiskRoleS100A8 geneSARS-CoV-2 infectionSARS-CoV-2 variantSamplingSiderophoresSpecimenStructure of parenchyma of lungTestingTherapeuticTissuesViralVirus Diseasesbronchial epitheliumchemokinecoronavirus diseasecytokinedigitalextracellularfungusimprovedin vivoinhibitorinnovationknock-downmortalitymouse modelmutantnano-stringneutrophilnovelpathogenic funguspathogenic viruspreventsevere COVID-19transcriptomics
中文摘要
项目摘要
与大多数侵袭性霉菌感染不同,COVID相关性肺曲霉病(CAPA)发生在
具有其他完整免疫系统的个体,提示新的生物学机制介导
易受真菌感染。该提案旨在评估新的概念性进展,
靶向细胞内病毒病原体的免疫应答损害人中性粒细胞的必需性
抗真菌效应子功能需要杀死大的细胞外真菌菌丝。在目标1中,我们将利用
BAL样本和尸检福尔马林固定石蜡包埋(FFPE)肺组织,以表征
人中性粒细胞抗真菌效应物的表达,上皮细胞坏死性凋亡,铁含量和真菌,
SARS-CoV-2和CAPA感染期间的呼吸道。在目标2中,我们将使用原发性细支气管
上皮细胞气液界面(ALI)培养物,CRISPR敲除细胞系(MLKL、RIPK 1、RIPK 3),
细胞死亡途径的化学抑制剂和中性粒细胞:真菌杀伤试验,以确定
SARS-CoV-2介导上皮细胞死亡、铁释放、霉菌生长和人类
中性粒细胞抗真菌效应功能。在目标3中,我们将利用一种新的CAPA感染小鼠模型,
中性粒细胞(MRP 8-Cre)和肺上皮细胞中人ACE 2表达的cre-lox敲低
(CC 10-Cre)沿着与缺铁真菌突变菌株(Δ ftrA、ΔftrA),以评价
SARS-CoV-2感染对肺上皮细胞坏死性凋亡、铁释放、铁载体依赖性真菌
生长和中性粒细胞募集/活化。我们认为,拟议研究的结果将有助于
对介导病毒相关的继发性霉菌感染的基础生物学的新认识,
能够开发改善的治疗方案,从而降低发生CAPA的风险。
英文摘要
Project summary
Unlike most invasive mold infections, COVID Associated Pulmonary Aspergillosis (CAPA) occurs in
individuals with otherwise intact immune systems suggesting novel biological mechanisms mediating
susceptibility to fungal infection. This proposal seeks to evaluate the novel conceptual advancement that
immune responses targeting intracellular viral pathogens compromise essential human neutrophil
antifungal effector functions required to kill large extracellular fungal hyphae. In Aim 1, we will utilize
BAL samples and autopsy formalin-fixed paraffin embedded (FFPE) lung tissues to characterize the
expression of human neutrophil antifungal effectors, epithelial cell necroptosis, iron content, and fungi in
the respiratory tract during SARS-CoV-2 and CAPA infection. In Aim 2, we will use primary bronchiolar
epithelial cell air-liquid interface (ALI) cultures, CRISPR knockout cell lines (MLKL, RIPK1, RIPK3),
chemical inhibitors of cell death pathways, and neutrophil:fungal killing assays to determine the
mechanism by which SARS-CoV-2 mediates epithelial cell death, iron release, mold growth, and human
neutrophil antifungal effector functions. In Aim 3, we will utilize a novel CAPA infection mouse model,
cre-lox knockdown of human ACE2 expression in neutrophils (MRP8-Cre) and lung epithelial cells
(CC10-Cre) along with iron-deficient fungal mutant strains (ΔsidA, ΔftrA), to evaluate the in vivo impact of
SARS-CoV-2 infection on lung epithelial cell necroptosis, iron release, siderophore-dependent fungal
growth, and neutrophil recruitment/activation. We believe that the results of the proposed study will shed
new light on the fundamental biology mediating viral-associated secondary mold infection which may
enable the development of improved therapeutic regimens that mitigate the risk of developing CAPA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
-
批准号:10658355
-
项目类别:
-
资助金额:$74.25万
-
财政年份:2023
-
负责人:Sixto Manuel Leal
-
依托单位:
Facility Management, Maintenance and Operations Core
-
批准号:10792751
-
项目类别:
-
资助金额:$140.11万
-
财政年份:2023
-
负责人:Sixto Manuel Leal
-
依托单位:
Enhancing SEBLAB Research Productivity, Operations and Core Laboratory Support
-
批准号:10792750
-
项目类别:
-
资助金额:$269.17万
-
财政年份:2023
-
负责人:Sixto Manuel Leal
-
依托单位:
Biocontainment Research Support Service(s) Core-Optional
-
批准号:10792753
-
项目类别:
-
资助金额:$84.2万
-
财政年份:2023
-
负责人:Sixto Manuel Leal
-
依托单位:
BSL-3 Practices Core
-
批准号:10792752
-
项目类别:
-
资助金额:$44.86万
-
财政年份:2023
-
负责人:Sixto Manuel Leal
-
依托单位:
Augmenting Scientific Discovery and Research Infrastructure in the UAB Regional Biocontainment Laboratory (SEBLAB)
-
批准号:10626482
-
项目类别:
-
资助金额:$433.0万
-
财政年份:2021
-
负责人:Sixto Manuel Leal
-
依托单位:
Upgrade and operational improvements to the SouthEastern Biosafety Laboratory, Alabama, Birmingham (SEBLAB)
-
批准号:10394580
-
项目类别:
-
资助金额:$333.0万
-
财政年份:2021
-
负责人:Sixto Manuel Leal
-
依托单位:
The Pathogenesis of Aspergillus Keratitis
-
批准号:7923157
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2009
-
负责人:Sixto Manuel Leal
-
依托单位:
The Pathogenesis of Aspergillus Keratitis
-
批准号:8128621
-
项目类别:
-
资助金额:$3.36万
-
财政年份:2009
-
负责人:Sixto Manuel Leal
-
依托单位:
The Pathogenesis of Aspergillus Keratitis
-
批准号:8326714
-
项目类别:
-
资助金额:$5.55万
-
财政年份:2009
-
负责人:Sixto Manuel Leal
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: